Background: The E-cadherin-catenin complex plays a crucial role in epitheli
al cell-cell adhesion and in the maintenance of tissue architecture. Pertur
bation in the expression or function of this complex results in loss of int
ercellular adhesion, with possible consequent cell transformation and tumou
r progression. Recently, much progress has been made in understanding the i
nteraction between the different components of this protein complex and how
this cell-cell adhesion complex is modulated in cancer cells.
Methods: This is an update of the role of the E-cadherin-catenin complex in
human cancers. It emphasizes new features and the possible role of the com
plex in clinical practice, discussed in the light of 165 references obtaine
d from the Medline database from 1995 to 1999.
Results: More evidence is now appearing to suggest that disturbance in prot
ein-protein interaction in the E-cadherin-catenin adhesion complex is one o
f the main events in the early and late steps of cancer development. hn inv
erse correlation is found between expression of the E-cadherin-catenin comp
lex and the invasive behaviour of tumour cells. Therefore, E-cadherin-caten
in may become a significant prognostic marker for tumour behaviour. Besides
its role in establishing tight cell-cell adhesion, beta-catenin plays a ma
jor role in cell signalling and promotion of neoplastic growth. This sugges
ts its dual role as a tumour suppressor and as an oncogene in human cancers
.
Conclusion: Recent developments show that the E-cadherin-catenin complex is
more than a 'sticky molecular complex'. Further studies may yield greater
insight into the early molecular interactions critical to the initiation an
d progression of tumours. This should aid the development of novel strategi
es for both prevention and treatment of cancer.